High Cholesterol Follow-Up Program for Private Clinics in Egypt: From Lipid Result to Recall
A high cholesterol follow-up program for a private clinic in Egypt is a routine that records each patient's lipid profile, treatment, next-check date and adherence questions, and chases missed visits. Egyptian data show why it matters: in the DYSIS-Egypt study, two-thirds of patients on chronic statin treatment still had elevated LDL-C.
Key takeaways
- In DYSIS-Egypt, a cross-sectional study of Egyptian patients on chronic statin treatment, two-thirds still had elevated LDL-C.
- In DYSIS II-Egypt, 199 patients hospitalized with an acute coronary syndrome were enrolled and 147 were on lipid-lowering therapy at admission. Among those with LDL-C data at admission and at the four-month follow-up, target attainment rose from 2.8% to 5.6%, and none of the patients with follow-up information reached an LDL-C below 70 mg/dL.
- A semi-systematic review of 22 Egyptian studies (1995 to 2020) reports medication adherence of 59% among dyslipidemia patients and control rates of 5.1 to 34.4% depending on cardiovascular risk. The most recent national survey it cites puts dyslipidemia prevalence at 19.2% and hypertension at 29.5%.
- A clinic can run the routine without new equipment: a registry, a lipid log, a next-check date for every patient, an adherence question at every contact, a missed-visit recall and a written referral rule. The doctor decides the treatment.

On this page
Why a lipid result is easy to lose
A raised cholesterol result rarely hurts. The patient feels well, the doctor starts or adjusts treatment, and the next lipid profile depends on the patient remembering to book it. The Egyptian review of hypertension and dyslipidemia care describes patients who are aware of the problem but undertreated and unable to reach target lipid levels while on treatment. The CEPHEUS study team concluded that hypercholesterolemia is still not being effectively managed in many at-risk patients in Egypt.
Many of these patients first appear in a private clinic: a family doctor, internist, diabetologist or cardiologist. If the clinic has no list, the lipid result lives in a paper report and the follow-up lives in the patient's memory.
What the Egyptian evidence shows
Three studies are worth knowing, with their limits.
DYSIS-Egypt found that, despite chronic statin treatment, two-thirds of patients had elevated LDL-C. It is an observational cross-sectional study, so it describes a situation; it does not say why.
DYSIS II-Egypt followed patients admitted with an acute coronary syndrome. LDL-C target attainment among those with data at both time points rose from 2.8% at admission to 5.6% at four months, and the authors called the goal attainment alarming. They note that most treated patients received statin monotherapy and that the mean daily statin dose (normalized to atorvastatin) rose from 30 to 42 mg between admission and follow-up. The sample was small and from two centres.
The semi-systematic review, which included 22 studies, highlights the gap between awareness and control and reports adherence of 59% among dyslipidemia patients. Its authors call for patient-centric management.
None of these are clinic audits, and none says a recall system would fix the numbers. They show that follow-up and control are weak points in Egypt, which is the problem a routine is designed to make visible.
What the program contains
The doctor sets the lipid targets, the test interval and any treatment change. The clinic's program makes sure everything around them happens:
- A registry. Every patient on lipid-lowering treatment or with a raised lipid result is listed with the diagnosis or risk reason, the responsible doctor and the date the plan was made.
- A lipid log. Each lipid profile, date and treatment note is recorded in the same place so the trend is visible at the next visit, not rebuilt from loose reports.
- A next-check date for every patient. The doctor sets it at each visit. It appears on a list, not only on a paper slip.
- An adherence question at every contact. One short, non-judgemental question: are you taking the medicine as prescribed, and if not, what gets in the way? Egyptian research highlights low adherence, so the answer is worth recording.
- A missed-visit recall. When the date passes, a named person contacts the patient within a set number of days, using a channel the patient agreed to.
- A risk-factor check. Blood pressure, glucose, weight and smoking status are recorded together with the lipid result, because lipid problems seldom travel alone. The clinic can reuse programs it already runs for diabetes, hypertension and obesity. A raised lipid profile can also sit alongside the findings in a fatty liver follow-up program.
- A referral rule. The doctor writes which patients go to a cardiologist or endocrinologist and which stay in the clinic, and the clinic tracks that the appointment happened. For patients with established cardiac disease, see our heart failure follow-up program.
Planning around Ramadan
Fasting changes meals, medicine timing and routines, and patients often ask whether to fast before a lipid test or how to take their medicine. The clinic should give the answer its doctor recommends, in writing, so every patient hears the same instruction. Listing lipid patients before Ramadan and confirming their next-check dates is a simple preparation step. See our guide to a Ramadan follow-up program for chronic disease.
What a digital tool adds, and what it does not
A tool can hold the registry, store each lipid profile with its date, show the next-check date, produce an overdue list every morning, send WhatsApp or SMS reminders to patients who agreed to them, and keep the adherence answers in view. It does not interpret a result, choose a drug or dose, or replace the doctor.
Data protection
Lipid and cardiovascular records are health data. Reminders should go only to patients who agreed to receive them, and family members should be added only with the patient's agreement. Egypt's Personal Data Protection Law (Law No. 151 of 2020) applies to personal data processing, so confirm consent, access and storage rules with your own legal adviser. See also our guide to patient data privacy under Law 151.
An illustrative scenario
This is a hypothetical example, not a real patient. A 56-year-old man in Mansoura with type 2 diabetes starts lipid-lowering treatment after a clinic visit. The nurse adds him to the registry, records his lipid profile and blood pressure, and the doctor sets the next-check date. On the day after the date, the list shows no new lipid result. The nurse calls, asks the adherence question, and learns that he stopped the tablets two weeks ago because he felt fine. She records the answer, the doctor speaks to him, and the next date goes on the list. The doctor's judgement did not change; what changed is that someone noticed the gap.
Start small
Pull the last three months of lipid profiles that came back raised. Count how many patients have a next-check date and a recorded adherence answer. That count is your baseline.
Frequently asked questions
What is a cholesterol follow-up program in a clinic?
It is a routine that records each patient's lipid profile, treatment and next-check date, asks about adherence, and recalls patients who miss a visit. The doctor decides targets and treatment.
How often should a lipid profile be repeated?
The interval is set by the doctor for each patient, according to risk and treatment. A clinic system stores the date and makes sure the recall happens; it does not choose the interval.
Which doctor should see a patient with high cholesterol, an endocrinologist or a cardiologist?
Often the first doctor is the family physician, internist or diabetologist, with a referral to a cardiologist or endocrinologist when the doctor judges it necessary. The clinic should write down who the patient sees next.
Does a patient need to fast before a lipid test?
Patients ask this often. The clinic should give the answer its doctor and the lab recommend, in writing, so every patient hears the same instruction.
Can the clinic send reminders for lipid checks?
Yes, if the patient agreed to receive them and the clinic follows its consent and data protection rules. Reminders work best when a named person acts on the overdue list.
Sources
- DYSIS-Egypt: prevalence of lipid abnormalities in Egyptian patients on chronic statin treatment. The Egyptian Heart Journal, 2013.
- DYSIS II-Egypt: hyperlipidemia in patients presenting with an acute coronary syndrome. The Egyptian Heart Journal, 2018.
- A semi-systematic review on hypertension and dyslipidemia care in Egypt: highlighting evidence gaps and recommendations for better patient outcomes. 2021.
- CEPHEUS II, Alexandria and Delta regions, Egypt: hypercholesterolemia management in patients on lipid-lowering drugs.
- Management and Follow-up of Dyslipidemia in Primary Health Care Setting. The Egyptian Journal of Hospital Medicine, 2018.